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Marine organisms have proven to be a valuable source of
modified purine bases and nucleosides. A number of methy-
lated guanine or isoguanine derivatives have been reported
from marine sponges1—4) and also from some ascidians.5—7)
In our continuing search for new bioactive marine natural
products, we have isolated a new purine base from a Philip-
pine sponge, Zyzzya fuliginosa (CARTER, 1879), together with
the known metabolites makaluvamines A (2), C (3), and K
(4) as well as 4-hydroxyphenylacetic acid (5), methyl ester of
4-hydroxyphenylacetic acid (6), 4-hydroxyphenethyl alcohol
(7), L-phenylalanine (8) and L-tryptophan (9). In this paper,
we describe the isolation and characterization of the new
compound, 3,7-dimethylguanine (1). 
Compound 1 was isolated as an amorphous white powder.
Both FAB-MS and electrospray ionization (ESI)-MS spectra
of 1 contained a pseudomolecular ion peak at m/z 180
([M1H]1). A molecular formula of C7H9N5O derived from
high resolution electron impact (HR-EI)-MS analysis (m/z
179.0803, D520.4 mmu) indicated the presence of six de-
grees of unsaturation. The 1H-NMR spectrum of 1 in D2O
(Table 1) was deceptively simple, containing two N-methyl
singlets at d 3.53 and 3.80 and one methine singlet at d 7.85.
In dimethyl sulfoxide (DMSO)-d6, the latter signal shifted to
d 8.14 and a very broad singlet appeared at d 8.66, indicat-
ing the presence of exchangeable protons. The 13C-NMR
spectrum of 1 displayed four quaternary carbons (d 110.5,
149.4, 152.4, 154.6), one methine (d 145.3) and two methyl
carbons (d 32.4, 34.5). These data, in conjunction with char-
acteristic UV absorptions (lmax 216, 268 nm), were sugges-
tive of a guanine or an isoguanine structure. The 3,7-methy-
lation pattern within 1 was determined by extensive 1H–15N
and 1H–13C heteronuclear multiple bond connectivity
(HMBC) experiments, both optimized for 8 Hz coupling
(Table 1). The methyl signal at dH 3.53 showed strong corre-
lations to dN 111.1 (N-3) and dC 149.4 (C-4), dC 152.4 (C-2),
dC 110.5 (C-5) and a weak correlation to dC 145.3 (C-8)
which positioned it at N-3. An 1H–15N HMBC cross peak
was observed from the other methyl function (dH 3.80) to a
nitrogen atom at dN 158.2 (N-7). Similar correlations ob-
tained between the methine function (d 7.85) and dN 158.2
(N-7) and dN 224.5 (N-9) suggested that the second methyl
group resided on the imidazole ring, either on N-7 or N-9.
Crucial long range 1H–13C couplings from this methyl group
to C-8 (d 145.3), C-5 (d 110.5), and C-6 (d 154.6) unam-
biguously located it at N-7. The latter correlation (N-7-
CH3/C-6) was also indicative of a guanine ring. Distinction
between the two possible structures, 3,7-dimethylguanine (1)
and 3,7-dimethylisoguanine (10) was made by MS. The frag-
mentation patterns of methylated purines have been investi-
gated.8,9) The initial expulsion of neutral cyanamide frag-
ments consisting of N-1, C-2, and their attached substituents
is a very characteristic fragmentation of the molecular ion
peak of these compounds. Since guanines contain an imino
substituent and isoguanines have an oxygen substitution at
the C-2 position, they can be easily distinguished by EI-MS
due to a one mass-unit difference.1,3) Thus, 1 showed a diag-
nostic ion at m/z 137.0595 due to loss of CH2N2 (m/z 42) via
a retro-Diels–Alder pathway. The positive mode tandem ESI-
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MS (n52) of 1 also yielded an abundant ion at m/z 138
([M2CH2N21H]
1). The corresponding EI fragmentation of
3,7-dimethylisoguanine (10), previously isolated from an
Agelas sponge, afforded a peak at m/z 136.0709 (M243).10)
Figure 1 illustrates the predicted EI-MS fragmentation pat-
terns of 1 and 10, obtained from the High Chem Mass Fron-
tier computer program. Final comparison of the NMR data of
1 with those of 10 further proved these two compounds to be
positional isomers. To the best of our knowledge, this is the
first report of 3,7-dimethylguanine (1) as a natural product.
Compound 1 has been prepared by methylation of guanine11)
or O6-methylguanine.12)
The cytotoxicity of 3,7-dimethylguanine (1) was evaluated
in human T-cell leukemia “IA2” (CCRF CEM) and human
colon carcinoma (HCT-116) cells. No significant activity was
observed at the highest concentrations tested (100 and
10 mg/ml, respectively). 
The known metabolites 2—4 were identified by compari-
son of their spectral data [one- and two-dimensional (1D,
2D) NMR, HR-MS] with those published.13,14) The structures
of compounds 5—9 were elucidated by 1D and 2D NMR and
confirmed by comparison of the EI-MS fragmentation pat-
terns with the NIST library of known compounds.
The marine sponge Zyzzya fuliginosa has been extensively
investigated for makaluvamine type pyrroloquinoline alka-
loids, some of which are substituted with 4-hydroxy-
phenethyl and L-tryptophan at N-9.11,12) It is interesting that
compounds 5—9 were also isolated in this study. This is the
first report of the isolation of a modified purine base from the
genus Zyzzya. Although 1 did not demonstrate bioactivity in
our test systems, the production of 3,7-dimethylguanine in
high yields in the sponge material might indicate an ecologi-
cal role for this metabolite.
Experimental
UV spectra were recorded in H2O on a Hewlett-Packard 8452A diode
array spectrophotometer. IR spectra were recorded on a Jasco FTIR-420
spectrophotometer, using a polyethylene IR card. NMR spectra were ob-
tained on a Varian instrument, operating at 500 MHz for 1H- and 125 MHz
for 13C-NMR spectra. NMR spectra were recorded in D2O (containing three
drops of CD3OD) and DMSO-d6 using the residual signal of nondeuterated
solvents as an internal reference. The 1H–15N HMBC experiment was opti-
mized for J58 Hz and chemical shifts were referenced indirectly to liquid
ammonia using CH3NO2 (10 m l in 450 m l D2O) as an internal standard. Mass
spectra were taken on Finnigan MAT 95 (EI-MS, FAB-MS) and Finnigan
LCQ DECA ion trap (ESI-MS) spectrometers. The NIST library for EI-MS
was used to compare the fragmentation patterns of the known compounds
5—9. Prediction of EI-MS fragmentation patterns for compounds 1 and 10
were made by High Chem Mass Frontier program (version 2.0). C-18 mater-
ial (J. T. Baker, 40 mm, 275 Å) was used for flash chromatography. Sephadex
LH-20 gel (25—200 mm bead size) was purchased from Sigma. HPLC sepa-
rations were performed on a Rainin Dynamax 60 Å semi-preparative column
(103250 mm, 8 mm, 4 ml/min) using a Beckman 168 photodiode array sys-
tem.
Animal Material The specimen of Zyzzya fuliginosa (phylum Porifera,
order Poecilosclerida) was collected by SCUBA (213 m) in Batanes, Philip-
pines, in 1999. A voucher specimen (ZMA POR. 16426) has been deposited
in the Zoölogisch Museum, University of Amsterdam.
Extraction and Isolation Frozen sponge material was soaked in MeOH
for 24 h and the solution decanted. This procedure was repeated two more
times. The combined MeOH extracts were dried in vacuo to give a reddish
residue. This residue was dissolved in 10% H2O in MeOH (200 ml) and par-
titioned against hexane (33200 ml). The water content of the MeOH phase
was then adjusted to 30% by adding 80 ml water before partitioning against
CHCl3. During the initial partition, an interphase formed between the
hexane and aqueous MeOH phases. An aliquot (100 mg) of this suspension
was dried and repartitioned between H2O and EtOAc. The H2O phase was
subjected to C-18 flash chromatography using a multistep MeOH gradient
(0—100% MeOH) in water [0.05% trifluoroacetic acid (TFA)]. 3,7-Di-
methylguanine (1, 24.0 mg) and makaluvamine A (2, 20 mg) were eluted
with 20 and 40% aqueous MeOH, respectively. 
The CHCl3-soluble material was further partitioned between EtOAc and
H2O. The EtOAc layer was applied to a C-18 flash column employing a
MeOH in water step gradient. Fractions containing 4-hydroxyphenethyl al-
cohol (7) were eluted with 20 and 30% MeOH. Compound 7 (5.1 mg) was
further purified by C-18 HPLC using 20% MeOH/80% aqueous TFA
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Table 1. 1H- (500 MHz) and 13C-NMR (125 MHz) Data of 3,7-Dimethylguanine (1) in D2O 
Position 1H-NMR 1H-NMRa,b) 13C-NMR 15N-NMRc)
1H–13C HMBC 1H–15N HMBC 
correlations correlationsc)
2 152.4 s
3 111.1
4 149.4 s
5 110.5 s
6 154.6 s
7 158.2
8 7.85 s 8.14 s 145.3 d 149.4 (C-4), 110.5 (C-5), 158.2 (N-7)
154.6 (C-6), 34.5 (N-7-Me) 224.5 (N-9)
9 224.5
N-3-Me 3.53 s 3.57 s 32.4 q 152.4 (C-2), 149.4 (C-4), 111.1 (N-3)
110.5 (C-5), 145.3 (C-8)
N-7-Me 3.80 s 3.89 s 34.5 q 145.3 (C-8), 110.5 (C-5), 158.2 (N-7)
154.6 (C-6)
a) Measured in DMSO-d6. b) A broad exchangeable signal was also observed at d 8.66. c) 15N chemical shifts were determined by 1H–15N HMBC experiment (8 Hz).
Fig. 1. Proposed EI-MS Fragmentation Pattern for Compounds 1 (a) and
10 (b) 
a : a cleavage, i: inductive transfer of electrons.
(0.05%).
The aqueous MeOH layer was repeatedly triturated with MeOH to remove
salts before partitioning between EtOAc and H2O. The EtOAc-soluble mate-
rial was fractionated by C-18 flash CC using 0 to 100% aqueous (0.05%
TFA) MeOH followed by a MeOH (0.1% TFA) rinse. Fractions eluting with
40 and 60% MeOH were combined and purified by HPLC [C-18 column,
30% MeOH/70% aqueous TFA (0.05%)] to yield 4-hydroxyphenylacetic
acid (5, 5 mg) and methyl ester of 4-hydroxyphenylacetic acid (6, 6.5 mg).
The water-soluble portion of the initial MeOH layer was partitioned against
n-BuOH. The n-BuOH layer was also separated by C-18 flash CC using the
same procedure as above. L-Phenylalanine (8) and makaluvamine C (3) were
eluted with 30% MeOH in aqueous TFA (0.05%). Fractions which eluted
with 40 and 60% MeOH were further purified by a combination of Sephadex
LH-20 chromatography (MeOH with 0.1% TFA) and C-18 HPLC
[MeOH : H2O : TFA (20 : 80 : 0.05%)] to provide makaluvamine K (4, 4 mg),
L-tryptophan (9, 3 mg) and additional makaluvamine A (2, 19 mg). 
3,7-Dimethylguanine (1): White amorphous solid; UV (H2O) lmax (log e)
216 (3.9), 268 (3.8) nm. IR (film, polyethylene card) nmax 3500—3350
(broad), 2915, 2361, 1758, 1621, 1465, 1258 cm21. EI-MS m/z 179 [M]1
(100), 137 (8), 109 (20), 82 (14), 67 (18), 55 (19). ESI-MS m/z 359
[2M1H]1, 180 [M1H]1, 163 [M2NH31H]
1. ESI-MS/MS (positive) m/z
138 [M2CH2N21H]
1. FAB-MS (positive) 180 [M1H]1, 149 (37), 93 (72),
75 (31). HR-EI-MS 179.0803 (Calcd for C7H9N5O, 179.0807); 137.0595
(Calcd for C6H7N3O, 137.0589), 109.0637 (Calcd for C5H7N3, 109.0640).
1H-NMR (500 MHz, D2O and DMSO-d6): Table 1; 
13C-NMR (125 MHz,
D2O with three drops of CD3OD): Table 1.
Cytotoxicity Assays The cytotoxic potential of 3,7-dimethylguanine (1)
against CCRF CEM (human T-cell leukemia) was measured as described by
Matsumoto et al.15) An MTT assay16) was used to determine the activity in
human colon carcinoma (HCT-116) cells.
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